Untersteiner Racing signs agreement for a pilot test
Diagonal Bio AB (publ) (“Diagonal Bio” or “the Company”) and Untersteiner Racing Aktiebolag (“Untersteiner Racing”), owned and run by Johan Untersteiner, have signed an agreement regarding a three-month pilot test of the LAMPlify® platform, starting end of October 2025.
Untersteiner Racing, founded by Johan Untersteiner in 2014, is a Swedish harness racing stable located at the farm “Drömgården” in Holm, outside Halmstad. The stable focuses on training, competition, and breeding of trotters. Untersteiner Racing work with long-term goals and maintain high standards of quality in every aspect – both for the horses and the staff. Led by the trainer Johan Untersteiner, who continues a proud family tradition, the stable operates as a close-knit and dedicated racing team. Over the years, they have achieved outstanding success and are consistently ranked among Sweden’s top-performing stables, with numerous victories both nationally and internationally.
“At Untersteiner Racing we are very excited to collaborate with Diagonal Bio and evaluate the LAMPlify platform. Innovation and precision are key values in our work, and we are always open to exploring new technologies that can help us optimise the health, performance, and well-being of our horses. This partnership is an interesting opportunity to combine cutting-edge science with top-level training.” – Johan Untersteiner, owner of Untersteiner Racing
“We are delighted to partner with Untersteiner Racing for this pilot. Johan Untersteiner is one of the most respected trotting coaches in Scandinavian, and his commitment to excellence aligns perfectly with our vision for LAMPlify.” – Karin Wehlin, CEO of Diagonal Bio AB (publ)
For additional information about Diagonal Bio, please contact:
Karin Wehlin, CEO
Phone: +46 70 305 24 88
E-mail: kw@diagonalbio.com
About Diagonal Bio
Diagonal Bio offers a point of care testing system for genetic markers that detects pathogens for viruses, bacteria and fungi. The system is approved for use in animals and current target markets are horses, small animals and fish farms. The Company has expertise in developing markers for eLAMP-testing that can be used on Diagonal’s own system or any other platform using LAMP technology, which creates a potential for licensing and partnerships in the future. Diagonal Bio was founded in 2020, is listed on NGM and headquartered in Lund, Sweden.
